Doctor profile · Federal record
Dr. Rachel Zelman, FNP-BC
Family Nurse Practitioner (CMS: Nurse Practitioner) · New York, NY
- NPI 1134700727
- Accepts Medicare
- 6 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
40 W 86Th St Apt 2A
New York, NY 100243605
(914) 330-1334
Credentials & registration
- NPI registered
- April 2021 — 5 yrs on file
- Year of graduation
- 2020 — 6 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- New York #347126
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1134700727. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
111
Distinct HCPCS
5
Medicare allowed
$10,339
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 41 | 28 | $87 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 23 | 15 | $123 | |
11102 |
Biopsy of related skin growth, first growth | 18 | 16 | $96 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 18 | 15 | $55 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 11 | 11 | $110 |
In context: peer comparison
Among 221 peers in this city , average services per provider: 100. This provider delivers 1.1× the peer median.Open Payments
Industry payments received
All-time total
$2,682
Transactions
114
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 35 | $648.25 | |
| UCB, Inc. | 14 | $330.97 | |
| Janssen Biotech, Inc. | 12 | $321.31 | |
| LEO Pharma Inc. | 8 | $246.01 | |
| Lilly USA, LLC | 7 | $170.17 | |
| GENZYME CORPORATION | 5 | $160.49 | |
| Arcutis Biotherapeutics, Inc. | 7 | $132.23 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $121.69 | |
| Novartis Pharmaceuticals Corporation | 5 | $115.15 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $104.30 | |
| Incyte Corporation | 4 | $81.10 | |
| Verrica Pharmaceuticals Inc. | 3 | $73.32 | |
| PFIZER INC. | 2 | $50.96 | |
| Dermavant Sciences, Inc. | 2 | $48.50 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $43.38 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
75
Patients
26
Total drug cost
$2,260
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 19 | 12 | $1,078 |
| Ketoconazole | Generic | 18 | 0 | $454 |
| Triamcinolone Acetonide | Generic | 16 | 14 | $176 |
| Ciclopirox | Generic | 11 | 0 | $430 |
| Mupirocin | Generic | 11 | 0 | $123 |
Hospital affiliations
Frequently asked questions
What is Dr. Rachel Zelman's medical specialty?
Dr. Rachel Zelman practices Family Nurse Practitioner in New York, NY.
Where does Dr. Rachel Zelman practice?
Dr. Rachel Zelman practices at 40 W 86Th St Apt 2A, New York, NY 100243605. Office phone: 9143301334.
What is Dr. Rachel Zelman's NPI?
Dr. Rachel Zelman's National Provider Identifier (NPI) is 1134700727, issued by NPPES.
Does Dr. Rachel Zelman accept Medicare assignment?
Yes. Dr. Rachel Zelman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rachel Zelman commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99214); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.